Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Autologous KRAS mutant TCR-transduced PBLs |
Synonyms | |
Therapy Description |
Autologous KRAS mutant TCR-transduced PBLs are peripheral blood lymphocytes engineered to express a T-cell receptor (TCR) specific for a KRAS mutation, which potentially induce cytotoxic T-lymphocyte (CTL)-dependent killing of tumor cells expressing mutant KRAS (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Autologous KRAS mutant TCR-transduced PBLs | Autologous KRAS mutant TCR-transduced PBLs are peripheral blood lymphocytes engineered to express a T-cell receptor (TCR) specific for a KRAS mutation, which potentially induce cytotoxic T-lymphocyte (CTL)-dependent killing of tumor cells expressing mutant KRAS (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|